DENVER, CO--(NewMediaWire - Aug 9, 2017) - Ubiquitech Software
Corp. (OTC PINK: UBQU), through its operating subsidiary
HempLifeToday™, is announcing its newest product line to be sold on
the new HempLifeToday.com Website. New CannazALL Pets™ will feature
CannazALL™ CBD products formulated specifically for pets and will
be available within the next 30-60 days.
According to the APPA (American Pet Products Association), US
residents spent over 60 billion dollars on pet products in 2015, up
from 58 billion in 2014, and the trend is growing. Of this amount
(in 2015), approximately 15 billion was spent on pet medications
alone, and this is the multi-billion dollar market the Company
expects CannazALL Pets™ to tap into.
Studies have shown that since all mammals have an
Endocannabinoid System, pets, like humans, can benefit from CBD
therapy the same as their owners. In fact, CBD has been shown to be
effective in pets for: pain, arthritis, seizures, epilepsy, even
anxiety, and more.
CEO James Ballas said, "It's remarkable all the
customers who contact us and tell us how well our CannazALL
products work for their pets, everything from pain management to
seizures, and in certain cases the pets were taken off of
medications altogether. This evidence, plus other information, and
the fact that we want to be one of the first, and the biggest, to
capture a large portion of this multi-billion dollar industry is
why we are moving ahead with this new product. CannazALL Pets will
be an exciting addition to our growing product line and we are
happy to be helping the pet population as well."
COO Luke Dreyer adds, "With CannazALL™ Pets we can
access pet owners through our extensive online reach, and be very
competitive on pricing. We intend to market this product
extensively as we proceed and with CannazALL Pets we can move into
more markets and capture the biggest piece of the pet spending pie
as possible."
The Company expects to have the introductory CBD products
specifically formulated for pets and their special dosing needs
available within the next 30-60 days, and the Company looks forward
to keeping shareholders informed of progress in its entry into this
multi-billion dollar market.
In addition, the Company is expecting to make an announcement
concerning the new HempLifeToday.com Website over the next
week.
About HempLife Today™
HempLife Today™ was created by a group of highly motivated,
skilled and health-minded people who have learned that Hemp, and
Hemp related products, can be a great source of increased health,
vitality, and overall well being in our lives. We also believe that
high grade CBD (Cannabidiol), could very well be the miracle
supplement the world has been waiting for as more and more people
discover the health benefits of this remarkable extract. HempLife
Today™ offers its quality CBD products
@ www.HempLifeToday.com
About Ubiquitech
Ubiquitech Software Corp., through its subsidiaries is a dynamic
multi-media, multi-faceted corporation utilizing state-of-the-art
global internet marketing, Direct Response (DRTV) Television,
Radio, Internet Content, and traditional marketing to drive traffic
to the new and emerging multi-billion dollar industries like its
subsidiaries HempLifeToday™ and CryptoBuy.com
HempLife Today™ focuses on the exciting and dynamic new thinking
in the world today that recognizes the important health and life
enriching enhancement that CBD Oil from the Hemp plant can bring.
Through its network of quality USA growers HempLifeToday.com™ has
developed multiple and proprietary CannazALL™ CBD oil products that
include its popular CBD Tinctures, Concentrated Oils, GelCaps, Skin
Salve, e-liquid, and CannazALL Pets CBD products all offered
@ www.HempLifeToday.com
CryptoBuy.com focuses on the burgeoning new world of Crypto
Currencies and is created to be a service to persons interested in
tracking and trading the many existing and future Crypto Currencies
worldwide.
This press release contains forward-looking statements. Words
such as "expects", "intends", "believes", and similar expressions
reflecting something other than historical fact are intended to
identify forward-looking statements, but are not the exclusive
means of identifying such statements. These forward-looking
statements involve a number of risks and uncertainties, including
the timely development and market acceptance of products and
technologies, the ability to secure additional sources of finance,
the ability to reduce operating expenses, and other factors
described in the Company's filings with the OTC Markets Group. The
actual results that the Company achieves may differ materially from
any forward-looking statement due to such risks and uncertainties.
The Company undertakes no obligation to revise or update any
forward- looking statements in order to reflect events or
circumstances that may arise after the date of this release.